217 related articles for article (PubMed ID: 33206698)
1. STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
Ramasamy T; Chen X; Qin B; Johnson DE; Grandis JR; Villanueva FS
PLoS One; 2020; 15(11):e0242264. PubMed ID: 33206698
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound enhanced siRNA delivery using cationic liposome-microbubble complexes for the treatment of squamous cell carcinoma.
Qin B; Chen X; Zhu J; Kopechek J; Helfield B; Yu F; Cyriac J; Lavery L; Grandis JR; Villanueva FS
Nanotheranostics; 2024; 8(3):285-297. PubMed ID: 38577322
[No Abstract] [Full Text] [Related]
3. Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth.
Kopechek JA; Carson AR; McTiernan CF; Chen X; Hasjim B; Lavery L; Sen M; Grandis JR; Villanueva FS
Theranostics; 2015; 5(12):1378-87. PubMed ID: 26681983
[TBL] [Abstract][Full Text] [Related]
4. STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma.
Klein JD; Sano D; Sen M; Myers JN; Grandis JR; Kim S
PLoS One; 2014; 9(1):e81819. PubMed ID: 24404126
[TBL] [Abstract][Full Text] [Related]
5. The effect of ultrasound pulse length on microbubble cavitation induced antibody accumulation and distribution in a mouse model of breast cancer.
Amate M; Goldgewicht J; Sellamuthu B; Stagg J; Yu FTH
Nanotheranostics; 2020; 4(4):256-269. PubMed ID: 33033688
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effects.
Sen M; Paul K; Freilino ML; Li H; Li C; Johnson DE; Wang L; Eiseman J; Grandis JR
Mol Med; 2014 Mar; 20(1):46-56. PubMed ID: 24395569
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
[TBL] [Abstract][Full Text] [Related]
8. Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R.
Shi K; Fang Y; Gao S; Yang D; Bi H; Xue J; Lu A; Li Y; Ke L; Lin X; Jin X; Li M
J Control Release; 2018 Jun; 279():53-68. PubMed ID: 29655990
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
10. Effect of STAT3 decoy oligodeoxynucleotides mediated by ultrasound-targeted microbubbles combined with ultrasound on the growth of squamous cell carcinoma of the esophagus.
Zhang Y; Zhang M; Fan X; Mao D; Lv S; Chen P
Oncol Lett; 2019 Feb; 17(2):2151-2158. PubMed ID: 30675281
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Induced Microbubble Cavitation for Targeted Delivery of MiR-29b Mimic to Treat Cardiac Fibrosis.
Feroze RA; Kopechek J; Zhu J; Chen X; Villanueva FS
Ultrasound Med Biol; 2023 Dec; 49(12):2573-2580. PubMed ID: 37749011
[TBL] [Abstract][Full Text] [Related]
12. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.
Sen M; Joyce S; Panahandeh M; Li C; Thomas SM; Maxwell J; Wang L; Gooding WE; Johnson DE; Grandis JR
Clin Cancer Res; 2012 Sep; 18(18):4986-96. PubMed ID: 22825581
[TBL] [Abstract][Full Text] [Related]
13. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
14. Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.
Boehm AL; Sen M; Seethala R; Gooding WE; Freilino M; Wong SM; Wang S; Johnson DE; Grandis JR
Mol Pharmacol; 2008 Jun; 73(6):1632-42. PubMed ID: 18326051
[TBL] [Abstract][Full Text] [Related]
15. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo.
Heath CH; Sorace A; Knowles J; Rosenthal E; Hoyt K
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):938-45. PubMed ID: 22323435
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.
Li C; Zang Y; Sen M; Leeman-Neill RJ; Man DS; Grandis JR; Johnson DE
Mol Cancer Ther; 2009 Aug; 8(8):2211-20. PubMed ID: 19638453
[TBL] [Abstract][Full Text] [Related]
17. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
18. Targeted Anti-Cancer Provascular Therapy Using Ultrasound, Microbubbles, and Nitrite to Increase Radiotherapy Efficacy.
Michon S; Rodier F; Yu FTH
Bioconjug Chem; 2022 Jun; 33(6):1093-1105. PubMed ID: 34990112
[TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
Xi S; Gooding WE; Grandis JR
Oncogene; 2005 Feb; 24(6):970-9. PubMed ID: 15592503
[TBL] [Abstract][Full Text] [Related]
20. First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.
Sen M; Thomas SM; Kim S; Yeh JI; Ferris RL; Johnson JT; Duvvuri U; Lee J; Sahu N; Joyce S; Freilino ML; Shi H; Li C; Ly D; Rapireddy S; Etter JP; Li PK; Wang L; Chiosea S; Seethala RR; Gooding WE; Chen X; Kaminski N; Pandit K; Johnson DE; Grandis JR
Cancer Discov; 2012 Aug; 2(8):694-705. PubMed ID: 22719020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
